Growth Metrics

Innoviva (INVA) Accumulated Depreciation & Amortization (2010 - 2013)

Innoviva posted quarterly Accumulated Depreciation & Amortization of $51.8 million for Q4 2013, up 4.83% year-on-year from $49.4 million in Q4 2012, and up 4.83% on a QoQ basis from $49.4 million in Q4 2012.

Innoviva (INVA) has 4 years of Accumulated Depreciation & Amortization data on file, last reported at $51.8 million in Q4 2013.

  • For the quarter ending Q4 2013, Accumulated Depreciation & Amortization rose 4.83% year-over-year to $51.8 million; the trailing twelve-month figure through Dec 2013 stood at $51.8 million (up 4.83% YoY), and the FY2013 full-year result was $51.8 million, up 4.83% from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2013 stood at $51.8 million, up from $49.4 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $51.8 million in Q4 2013 and bottomed at $43.6 million in Q4 2010.
  • The 4-year median for Accumulated Depreciation & Amortization is $48.4 million (2011), against an average of $48.1 million.
  • The widest annual swing landed in 2011, when Accumulated Depreciation & Amortization gained 8.58%; it then gained 4.28% in 2012.
  • A 4-year view of Accumulated Depreciation & Amortization shows it stood at $43.6 million in 2010, then grew by 8.58% to $47.4 million in 2011, then rose by 4.28% to $49.4 million in 2012, then rose by 4.83% to $51.8 million in 2013.
  • The last three Accumulated Depreciation & Amortization figures came in at $51.8 million (Q4 2013), $49.4 million (Q4 2012), and $47.4 million (Q4 2011), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Innoviva 1.60 Bn 992.84 Mn 75.83 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2013 51.81 Mn
Dec 31, 2013 51.81 Mn
Dec 31, 2012 49.42 Mn
Dec 31, 2012 49.42 Mn
Dec 31, 2011 47.39 Mn
Dec 31, 2011 47.39 Mn
Dec 31, 2010 43.65 Mn
Dec 31, 2010 43.65 Mn